News

Find News

Filter articles

Showing 3451 to 3460 of 3629 results

EIP hires Teva litigator

UK07-01-2014

EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.

Enzo sees Applera damages rise to $61 million

US07-01-2014

Enzo Biochem, a US biotechnology company, has received another $12.4 million from a patent ruling against Applera Corp, bringing the total damages sum to around $61 million.

Edwards Wildman promotes IP litigator

US06-01-2014

IP litigator Thomas Wintner has been appointed partner at Edwards Wildman Palmer LLP.

AstraZeneca buys Bristol out of diabetes venture

UK, US20-12-2013

Biopharmaceutical company AstraZeneca has paid $4.1 billion to acquire Bristol Myers Squibb’s share of the firms’ diabetes business venture.

Pfizer allows Teva’s generic Viagra

US19-12-2013Legal developments

Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets.

US district court upholds ViiV HIV patent

US19-12-2013Legal developments

The US District Court for the District of Delaware has upheld the validity of a GSK-held patent that covers two HIV drugs marketed in the US by ViiV Healthcare.

Mylan settles with Eisai in Targretin case

US18-12-2013Legal developments

Mylan Pharmaceuticals and its partner Banner Pharmacaps Inc, a subsidiary of Patheon Inc, have entered into a settlement and licence agreement with Japanese pharmaceutical company Eisai Inc and Valeant Pharmaceuticals Luxembourg S.a.r.l.

AstraZeneca challenges Aurobindo’s proposed Nexium generic

17-12-2013

AstraZeneca has sued Aurobindo Pharma Limited and its US-based subsidiary Aurobindo Pharma USA Inc for infringing four of its patents related to heartburn drug Nexium.

Battistelli buoyant on Unitary Patent

EU17-12-2013

European Patent Office president Benoît Battistelli has praised the “steady” progress that the Unitary Patent and its associated court have made this year.

FDA approves first generic versions of Lilly’s $5bn Cymbalta

US16-12-2013

The US Food and Drug Administration (FDA) has approved the first generic versions of antidepressant drug Cymbalta (duloxetine hydrochloride), after Eli Lilly’s primary patent covering the product expired on December 11.

Showing 3451 to 3460 of 3629 results

LSIPR